Junya Kuroda

7.1k total citations
217 papers, 4.7k citations indexed

About

Junya Kuroda is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Junya Kuroda has authored 217 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Hematology, 76 papers in Pathology and Forensic Medicine and 75 papers in Oncology. Recurrent topics in Junya Kuroda's work include Lymphoma Diagnosis and Treatment (60 papers), Multiple Myeloma Research and Treatments (40 papers) and Chronic Lymphocytic Leukemia Research (35 papers). Junya Kuroda is often cited by papers focused on Lymphoma Diagnosis and Treatment (60 papers), Multiple Myeloma Research and Treatments (40 papers) and Chronic Lymphocytic Leukemia Research (35 papers). Junya Kuroda collaborates with scholars based in Japan, United States and Australia. Junya Kuroda's co-authors include Shinya Kimura, Masafumi Taniwaki, Taira Maekawa, Asumi Yokota, Andreas Strasser, Hidekazu Segawa, Takeshi Yuasa, David C.S. Huang, Hamsa Puthalakath and Mark S. Cragg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Junya Kuroda

201 papers receiving 4.6k citations

Peers

Countries citing papers authored by Junya Kuroda

Since Specialization

Citations

This map shows the geographic impact of Junya Kuroda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junya Kuroda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junya Kuroda more than expected).

Fields of papers citing papers by Junya Kuroda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junya Kuroda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junya Kuroda. The network helps show where Junya Kuroda may publish in the future.

Co-authorship network of co-authors of Junya Kuroda

This figure shows the co-authorship network connecting the top 25 collaborators of Junya Kuroda. A scholar is included among the top collaborators of Junya Kuroda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junya Kuroda. Junya Kuroda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	B-cell maturation in angioimmunoblastic T cell lymphoma (AITL): Development of secondary diffuse large B cell lymphoma (DLBCL) is likely associated with Attygalle patterns II and III 2024 ·Medical Research Archives ·(unknown), (unknown), Junya Kuroda	1
2	Skeletal muscle index impacts the treatment outcome of elderly patients with diffuse large B cell lymphoma 2024 ·Hematological Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), Takahiro Fujino, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Satoshi Teramukai, Junya Kuroda	6
3	Autologous HSCT with novel agent‐based induction and consolidation followed by lenalidomide maintenance for untreated multiple myeloma 2024 ·Cancer Science ·Yasuo Mori, Jun Takizawa, (unknown), Naoki Takezako, Koji Nagafuji, Hiroshi Handa, Junya Kuroda, Kazutaka Sunami, Tomohiko Kamimura, Ryosuke Ogawa, Yoshikane Kikushige, Mine Harada, Koichi Akashi, Toshihiro Miyamoto, (unknown)	1
4	Robust anti-myeloma effect of TAS0612, an RSK/AKT/S6K inhibitor, with venetoclax regardless of cytogenetic abnormalities 2024 ·Leukemia ·(unknown), Shinsuke Mizutani, Taku Tsukamoto, (unknown), (unknown), (unknown), (unknown), (unknown), Takahiro Fujino, Yuji Shimura, K. Ichikawa, Junya Kuroda	1
5	Progressive Multifocal Leukoencephalopathy Initially Suspected As Brain Relapse From Classical Hodgkin’s Lymphoma 2023 ·Cureus ·Akio Onishi, (unknown), Yuji Shimura, (unknown), Takahiro Fujino, Shinsuke Mizutani, Taku Tsukamoto, Yukiko Shishido‐Hara, Junya Kuroda	0
6	An Open-Label, Multicenter, Single-Arm, Phase I Dose Escalation Study of OP-2100, an Orally Bioavailable Prodrug of Decitabine, for Patients with Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia 2023 ·Blood ·Shinya Kimura, Kensuke Usuki, Tatsuo Ichinohe, Takayuki Ikezoe, Junya Kuroda, Senji Kasahara, Sho Okamoto, (unknown), Hiroshi Ureshino, Tatsuro Watanabe, (unknown), (unknown), (unknown), (unknown), Toshiki Naito, Takahiro Yamauchi	1
7	Impact of Treatment with Anti-CD20 Monoclonal Antibody on the Production of Neutralizing Antibody Against Anti–SARS-CoV-2 Vaccination in Mature B-Cell Neoplasms 2023 ·Infection and Drug Resistance ·Akio Onishi, (unknown), Shinsuke Mizutani, Taku Tsukamoto, Takahiro Fujino, (unknown), (unknown), Kazuho Shimura, Hiroto Kaneko, Eri Kawata, Ryoichi Takahashi, Tsutomu Kobayashi, Hitoji Uchiyama, Nobuhiko Uoshima, Yoko Nukui, Yuji Shimura, Tohru Inaba, Junya Kuroda	3
8	Pleomorphic rhabdomyosarcoma in a young adult harboring a novel germline MSH2 variant 2022 ·Human Genome Variation ·(unknown), Tomohiro Chiyonobu, Shinsaku Tokuda, Mitsuru Miyachi, (unknown), Makoto Hirata, Masanori Nakagawa, Tomoko Iehara, Junya Kuroda, Koichi Takayama	4
9	The outcome of watchful waiting in patients with previously treated follicular lymphoma 2022 ·Cancer Medicine ·Takahiro Fujino, Dai Maruyama, (unknown), (unknown), (unknown), (unknown), (unknown), Shinichi Makita, Suguru Fukuhara, Wataru Munakata, Tatsuya Suzuki, Junya Kuroda, Koji Izutsu	4
10	Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohort 2022 ·Cancer Science ·Masaki Ri, Kenshi Suzuki, Tadao Ishida, Junya Kuroda, Taku Tsukamoto, Takanori Teshima, Hideki Goto, Carolyn C. Jackson, (unknown), Lida Pacaud, (unknown), Tzu‐Min Yeh, (unknown), (unknown), (unknown), Shinsuke Iida	12
11	Clinical Implication of the Effect of the Production of Neutralizing Antibodies Against SARS-Cov-2 for Chronic Immune Thrombocytopenia Flare-Up Associated with COVID-19 Infection: A Case Report and the Review of Literature 2022 ·Infection and Drug Resistance ·(unknown), (unknown), Hiroaki Nagata, (unknown), Akio Onishi, (unknown), (unknown), Takahiro Fujino, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Tsutomu Kobayashi, (unknown), Tohru Inaba, Yoko Nukui, Junya Kuroda	1
12	Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa‐associated lymphoid tissue lymphoma: A retrospective study 2022 ·Cancer Medicine ·(unknown), Tsutomu Kobayashi, Mitsushige Nakao, Ryoichi Takahashi, Hiroto Kaneko, Kazuho Shimura, (unknown), Nobuhiko Uoshima, Katsuya Wada, Eri Kawata, (unknown), Takahiro Fujino, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, (unknown), Akihide Watanabe, Chie Sotozono, Junya Kuroda	4
13	Combination of Bone Marrow Biopsy and Flow Cytometric Analysis: The Prognostically Relevant Central Approach for Detecting Bone Marrow Invasion in Diffuse Large B-Cell Lymphoma 2021 ·Diagnostics ·(unknown), Nobuhiko Uoshima, (unknown), (unknown), Takahiro Fujino, (unknown), Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Tsutomu Kobayashi, Eri Kawata, Hitoji Uchiyama, Junya Kuroda	5
14	Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma 2018 ·Cancer Science ·Shinsuke Iida, Masashi Wakabayashi, Kunihiro Tsukasaki, Ken‐ichi Miyamoto, Dai Maruyama, Kazuhito Yamamoto, Y Takatsuka, Shigeru Kusumoto, Junya Kuroda, Kiyoshi Ando, Yoshitaka Kikukawa, Yasufumi Masaki, Miki Kobayashi, Ichiro Hanamura, Hiroaki Asai, Hirokazu Nagai, Kazuyuki Shimada, Norifumi Tsukamoto, (unknown), Kensei Tobinai	5
15	Phosphoinositide Protein Kinase PDPK1 Is a Crucial Cell Signaling Mediator in Multiple Myeloma 2014 ·Cancer Research ·Yoshiaki Chinen, Junya Kuroda, Yuji Shimura, Hisao Nagoshi, Miki Kiyota, Mio Yamamoto‐Sugitani, Shinsuke Mizutani, Natsumi Sakamoto, Masaki Ri, Eri Kawata, Tsutomu Kobayashi, Yosuke Matsumoto, Shigeo Horiike, Shinsuke Iida, Masafumi Taniwaki	28
16	RSK2Ser227 at N-Terminal Kinase Domain Is a Potential Therapeutic Target for Multiple Myeloma 2012 ·Molecular Cancer Therapeutics ·Yuji Shimura, Junya Kuroda, Masaki Ri, Hisao Nagoshi, Mio Yamamoto‐Sugitani, Tsutomu Kobayashi, Miki Kiyota, (unknown), Shinsuke Mizutani, Yoshiaki Chinen, Natsumi Sakamoto, Yosuke Matsumoto, Shigeo Horiike, Yukimasa Shiotsu, Shinsuke Iida, Masafumi Taniwaki	28
17	Frequent PVT1 Rearrangement and Novel Chimeric Genes PVT1-NBEA and PVT1-WWOX Occur in Multiple Myeloma with 8q24 Abnormality 2012 ·Cancer Research ·Hisao Nagoshi, Tomohiko Taki, Ichiro Hanamura, Masakazu Nitta, Takemi Otsuki, Kazuhiro Nishida, Keiko Okuda, Natsumi Sakamoto, Satoru Kobayashi, Mio Yamamoto‐Sugitani, Yasuhiko Tsutsumi, Tsutomu Kobayashi, Yosuke Matsumoto, Shigeo Horiike, Junya Kuroda, Masafumi Taniwaki	82
18	Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia 2010 ·Molecular Cancer Research ·Junya Kuroda, (unknown), Hisao Nagoshi, Tsutomu Kobayashi, Nana Sasaki, Yuji Shimura, Shigeo Horiike, Shinya Kimura, Akira Yamauchi, (unknown), Masafumi Taniwaki	61
19	Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer 2008 ·Molecular Cancer Therapeutics ·(unknown), Eishi Ashihara, Shinya Kimura, Kazumasa Takenaka, Kiyoshi Sato, Ruriko Tanaka, Asumi Yokota, Yuri Kamitsuji, Miki Takeuchi, Junya Kuroda, Fumihiro Tanaka, Toshikazu Yoshikawa, Taira Maekawa	47
20	Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer 2005 ·Journal of Clinical Investigation ·Masaki Nogawa, Takeshi Yuasa, Shinya Kimura, Motoyoshi Tanaka, Junya Kuroda, Kiyoshi Sato, Asumi Yokota, Hidekazu Segawa, Yoshinobu Toda, Susumu Kageyama, Tatsuhiro Yoshiki, Yusaku Okada, Taira Maekawa	165

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact